Loading…
Reported covered position: Deputy Chief of Staff -- Larry Bucshon
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2026 · third_quarter · Q3
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Source: Senate LDA
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests.
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
RESULTS Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
RESULTS Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
RESULTS Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Care Cybersecurity and Resiliency Act of 2026
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Health Care Cybersecurity and Resiliency Act of 2026
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Countering CCP Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Countering CCP Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.
RESULTS Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
RESULTS Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Health Tech Investment Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
National Defense Authorization Act for Fiscal Year 2026
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838
National Defense Authorization Act for Fiscal Year 2026
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Improving Development and Distribution of Diagnostic Tests Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Improving Development and Distribution of Diagnostic Tests Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Medical Device Nonvisual Accessibility Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Nonvisual Accessibility Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Nonvisual Accessibility Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
VALID Act of 2023
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Electronic Labeling Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
To amend the Public Health Service Act to require the development of a diagnostic testing preparedness plan to be used during public health emergencies, and for other purposes.
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Saving Access to Laboratory Services Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Improving Development and Distribution of Diagnostic Tests Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Improving Development and Distribution of Diagnostic Tests Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Improving Development and Distribution of Diagnostic Tests Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Improving Development and Distribution of Diagnostic Tests Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Medical Device Recall Improvement Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Biking on Long-Distance Trails Act
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
Client: ADVANCED MEDICAL TECHNOLOGY ASSN · Firm: ADVANCED MEDICAL TECHNOLOGY ASSN
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to small business taxes
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2026 · second_quarter · Q2
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to small business taxes
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2026 · first_quarter · Q1
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to small business taxes
Issues related to appropriations and user fee funding for the Food and Drug Administration
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests.
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2025 · fourth_quarter · Q4
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838 Issues related to FDA regulation of diagnostic tests.
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to R&D Expense Amortization Issues related to small business taxes Issues related to capital investment expensing Issues related to Qualified Small Business Stock
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Japan Reimbursement
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes. Issues related to Qualified Small Business Stock.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2025 · third_quarter · Q3
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR) Issues related to National Defense Authorization Act S. 2296/H.R. 3838
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to R&D Expense Amortization Issues related to small business taxes Issues related to capital investment expensing Issues related to Qualified Small Business Stock
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Japan Reimbursement
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes. Issues related to Qualified Small Business Stock.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2025 · second_quarter · Q2
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program Issues related to the President's Emergency Program for AIDS Relief (PEPFAR)
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2025 · first_quarter · Q1
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to Medicare coverage of FDA's breakthrough devices
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2024 · fourth_quarter · Q4
Issues related to appropriations and user fee funding for the Food and Drug Administration Issues related to appropriations for AI reimbursement and focused ultrasound
Issues related to R&D Expense Amortization
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2024 · third_quarter · Q3
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to TRIPS Waiver Extension
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2024 · second_quarter · Q2
Issues related to TRIPS Waiver Extension
Issues related to R&D Expense Amortization
Issues related to appropriations and user fee funding for the Food and Drug Administration
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2024 · first_quarter · Q1
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to the reauthorization of the Small Business Tech Transfer (STTR) program. Issues related to the reauthorization of the Small Business Investment Company (SBIC) program.
Issues related to Japan Reimbursement Issues related to TRIPS Waiver Extension
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2023 · fourth_quarter · Q4
Issues related to Japan Reimbursement Issues related to TRIPS Waiver Extension
Issues related to R&D Expense Amortization
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2023 · third_quarter · Q3
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to the reauthorization of the Small Business Tech Transfer (STTR) program. Issues related to the reauthorization of the Small Business Investment Company (SBIC) program.
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to R&D Expense Amortization
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2023 · second_quarter · Q2
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to the reauthorization of the Small Business Tech Transfer (STTR) program. Issues related to the reauthorization of the Small Business Investment Company (SBIC) program.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2023 · first_quarter · Q1
Issues related to Protecting Access to Medicare Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610) Issues related to physician fee schedule Issues related to H.R. 3173/S. 3018 Improving Seniors Timely Access to Care Issues related to H.R. 4043 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to H.R. S. 4449/H.R. 8188 Saving Access to Laboratory Services Act
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador Issues related to TRIPS Waiver Extension Issues related to H.R. 7185/S. 4930 Federal Contracting for Peace and Security Act Issues related to Section 875 of 2023 NDAA Prohibition on Certain Semiconductor Products and Services
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2022 · fourth_quarter · Q4
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs
Issues related to Protecting Access to Medicare Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610) Issues related to physician fee schedule Issues related to H.R. 3173/S. 3018 Improving Seniors Timely Access to Care Issues related to H.R. 4043 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to H.R. S. 4449/H.R. 8188 Saving Access to Laboratory Services Act
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2022 · third_quarter · Q3
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to HR 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues related to S. 4386, A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan. Issues related to S. 3799, PREVENT Pandemics Act
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2022 · second_quarter · Q2
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to HR 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act Issues related to S. 4386, A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan. Issues related to S. 3799, PREVENT Pandemics Act
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2022 · first_quarter · Q1
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2021 · fourth_quarter · Q4
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act Section 1202 - Qualified Small Business Stock Issues related to R&D Tax Credit
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to HR 4043 - Ensuring Access to Critical Breakthrough Products Act Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610)
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2021 · third_quarter · Q3
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act Section 1202 - Qualified Small Business Stock
Issues related to appropriations and user fee funding for the Food and Drug Administration FY2021 Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2021 · second_quarter · Q2
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to Buy America Act Issues related to Free Agreement with Ecuador
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to R&D Tax Credit Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2021 · first_quarter · Q1
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related CBC Health Braintrust Clinical Trials Issues related to the PASTEUR Act Issues related to HR 1319/S 2401 Rescue America Plan
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2020 · fourth_quarter · Q4
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience
Issues related to appropriations and user fee funding for the Food and Drug Administration FY2021 Appropriations - Labor, Health and Human Services, Education, and Related Agencies FY2021 Appropriations for CDC and BARDA
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2020 · third_quarter · 3A
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2020 · third_quarter · Q3
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2020 · second_quarter · Q2
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests.
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2020 · first_quarter · Q1
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Issues related to implementation of the 21st Century Cures Act Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues related to the competitiveness of the medical technology industry and the impact of Federal policies Issues related to implementation of PL 115-271, the SUPPORT Act, and policies related to the opioid crisis
ADVANCED MEDICAL TECHNOLOGY ASSN via ADVANCED MEDICAL TECHNOLOGY ASSN
2019 · fourth_quarter · Q4
Issues related to implementation of the 21st Century Cures Act Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to cybersecurity for medical technology Issues related to cybersecurity and government procurement Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices
H.R. 2207, S. 692, and related bills related to repeal of the medical device excise tax Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Issues related to appropriations and user fee funding for the Food and Drug Administration Issues related to appropriations for AI reimbursement and focused ultrasound
Issues related to R&D Expense Amortization
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Export Controls on Biotech lab equipment US Brazil ATEC Protocol Japan Reimbursement
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Issues related to appropriations and user fee funding for the Food and Drug Administration Issues related to appropriations for AI reimbursement and focused ultrasound
Issues related to R&D Expense Amortization
Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs Export Controls on Biotech lab equipment US Brazil ATEC Protocol
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology Issues related to FDAs third party review program
Issues related to domestic supply chain resilience Issues related to the UN Plastics Treaty Issues related to global supply chain resilience Issues related Italy claw back regulations issues related to EU regulations: MDR/IVDR; chemical regulations; data regulations
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Issues related to R&D Expense Amortization
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program.
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness (including Pandemic All Hazards Preparedness Act reauthorization) Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 3723 - the Medical Device Electronic Labeling Act HR 5662/S 2907 - the Medical Device Recall Improvement Act S 2672 - Improving Development and Distribution of Diagnostic Tests Act HR 3795 - Diagnostic Testing Preparedness Plan Reimbursement and coverage of focused ultrasound technology HR 1328, the Medical Device Nonvisual Accessibility Act of 2023 Issues related to FDAs third party review program
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to R&D Expense Amortization
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to the reauthorization of the Small Business Tech Transfer (STTR) program. Issues related to the reauthorization of the Small Business Investment Company (SBIC) program.
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Issues related to appropriations and user fee funding for the Food and Drug Administration
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act Issues related to SALSA
Issues related to Privacy Legislation Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to Public Health Emergency Preparedness Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation
Issues related to Japan Reimbursement Issues related to TRIPS Waiver Extension
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to Protecting Access to Medicare Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to physician fee schedule Issues related to H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 1000/H.R. 2377 Saving Access to Laboratory Services Act
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador Issues related to TRIPS Waiver Extension
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to R&D Expense Amortization Issues related to Section 1202 - Qualified Small Business Stock
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests VALID Act of 2023 - H.R. 2369. Issues related to Health Equity Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to H.R. 6833 Continuing Appropriations and Ukraine Supplemental Appropriations Act Issues related to cyber security including H.R. 7084/S. 3983, PATCH Act and S. 4336 Strengthening Cybersecurity for Medical Devices Act
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to the reauthorization of the Small Business Tech Transfer (STTR) program. Issues related to the reauthorization of the Small Business Investment Company (SBIC) program.
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Section 1202 - Qualified Small Business Stock Issues related to R&D Expense Amortization Issues related to Section 1202 - Qualified Small Business Stock
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests Issues related to the Valid Act of 2021 - H.R. 4128/S. 2209 Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act Issues related to H.R. 7667, Food and Drug Amendments of 2022 Issues related to S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Issues related to S. 4386, A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan. Issues related to S. 3799, PREVENT Pandemics Act Issues related to S. 3700 Prevent Pandemics Act Issues related to H.R. 2617 Consolidated Appropriations Act Issues related to H.R. 6833 Continuing Appropriations and Ukraine Supplemental Appropriations Act Issues related to S. 4349 A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to notifications of emerging signals concerning devices. Issues related to H.R. 7676 Emerging Signals Modernization Act of 2022 Issues related to cyber security including H.R. 7084/S. 3983, PATCH Act and S. 4336 Strengthening Cybersecurity for Medical Devices Act
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador Issues related to TRIPS Waiver Extension Issues related to H.R. 7185/S. 4930 Federal Contracting for Peace and Security Act Issues related to Section 875 of 2023 NDAA Prohibition on Certain Semiconductor Products and Services
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Section 1202 - Qualified Small Business Stock Issues related to R&D Expense Amortization Issues related to Section 1202 - Qualified Small Business Stock
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act Section 1202 - Qualified Small Business Stock Issues related to R&D Tax Credit Issues related to Section 1202 - Qualified Small Business Stock
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador Issues related to TRIPS Waiver for COVID-19 diagnostic & treatment products Issues related to USICA/Competes
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610)
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act Section 1202 - Qualified Small Business Stock Issues related to R&D Tax Credit Issues related to Section 1202 - Qualified Small Business Stock
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act Issues related to HR 1319/S 2401 Rescue America Plan
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610)
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador Issues related to TRIPS Waiver for COVID-19 diagnostic & treatment products Issues related to USICA/Competes
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act Section 1202 - Qualified Small Business Stock Issues related to R&D Tax Credit
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy Issues related to MDUFA Reauthorization
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies Issues related to Protecting Medicare and American Farmers from Sequesters Act (S.610)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness Issues related to PFAS Chemical regulation, H.R. 2457 PFAS Action Act COVID-19 Clinical Testing and Testing Supplies Issues related to consumer and health data privacy
Issues related to appropriations and user fee funding for the Food and Drug Administration Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to IGNITE America Innovation Act
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of telehealth services Issues related to HR 4043 - Ensuring Access to Critical Breakthrough Products Act Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to trade with the EU and Switzerland, specifically MDR/IVDR implementation and regulatory issues caused by Swiss exit from the EU Issues related to Free Agreement with Ecuador
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2021 - HR 4128/S. 2209 Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act of 2021 - S. 2076/HR 3932 Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act Issues related to the Critical Medical Infrastructure Right-to-Repair Act Issues related to Health Equity Issues related to the PASTEUR Act Issues related to HR 1319/S 2401 Rescue America Plan Issues related to COVID-19 Clinical Testing & Testing Supplies Issues related to Public Health Emergency Preparedness
Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of diabetes technology Issues related to coverage of telehealth services Issues related to HR 5333 - Ensuring Access to Critical Breakthrough Products Act Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies
Issues related to appropriations and user fee funding for the Food and Drug Administration FY2021 Appropriations - Labor, Health and Human Services, Education, and Related Agencies Issues related to HR 1319/S 2401 Rescue America Plan Issues related to IGNITE America Innovation Act
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office
Issues related to appropriations and user fee funding for the Food and Drug Administration FY2021 Appropriations - Labor, Health and Human Services, Education, and Related Agencies FY2021 Appropriations for CDC and BARDA Issues related to HR 1319/S 2401 Rescue America Plan Issues related to IGNITE America Innovation Act
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues related to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to mdufa payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act Issues related to Medicare coverage reform Issues related to coverage of diabetes technology Issues related to coverage of telehealth services Issues related to HR 5333 - Ensuring Access to Critical Breakthrough Products Act Issues related to Medicare Coverage for Innovative Technology Final Rule Issues related to Medicare coverage for digital health technologies
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies. Issues related to R&D Tax Credit Issues related to Corporate Tax Policy Issues related to IGNITE America Innovation Act
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience Issues related to Buy America Act
Issues related to the reauthorization of the Small Business Innovation Research (SBIR), Small Business Tech Transfer (STTR), and Small Business Investment Company (SBIC) programs, as well as R&D Tax Credits.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR), White House Office
Issues related to deficit reduction and Medicare Issues related to value-based health care and Medicare program integrity, including changes to the Stark laws and Anti-Kickback Statute Issues relating to payment reform, ACOs and bundling Issues related to Protecting Access to Medicare Act Issues related to diagnostics payment reform Issues related to the regulation of, reimbursement for, and access to cancer diagnostics, imaging, and radiation therapies, including passage of H.R. 1892, Bipartisan Budget Act of 2018 Issues related to Medicare coverage reform Issues related to coverage of diabetes technology Issues related to coverage of telehealth services
Issues related to the implementation of PL 115-52, The Food and Drug Administration Reauthorization Act Issues related to the medical supply chain Issues related to implementation of the 21st Century Cures Act Issues related to the competitiveness of the medical technology industry and the impact of Federal Policies. Issues related to third party servicing of medical devices Issues related to diagnostics regulation Issues related to promoting innovation in the med tech industry and improving FDA regulatory processes and procedures for devices Issues related to medical technology and the opioid crisis Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to the implementation of H.R.5997 - The Emergency Response Coordinator Act of 2020 Issues related to the implementation of H.R.748 - CARES Act Issues relating to Paycheck Protection Program and Health Care Enhancement Act Issues related to coverage and reimbursement of COVID-19 diagnostic tests. Issues related to the Valid Act of 2020. Implementation of Laboratory Access for Beneficiaries (LAB) Act Improving Medical Device Servicing to Protect Patient Safety Act
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Filing targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to the Phase I Trade Agreement with China Issues related to the Free Trade Agreement with Brazil Issues related to the Free Trade Agreement with Kenya Issues related to US MADE and domestic supply chain resilience
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to the reform of the tax code and tax credits for investors in pre-revenue and start-up medical technology companies.
Issues related to appropriations and user fee funding for the Food and Drug Administration
Filing targets: Environmental Protection Agency (EPA), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to appropriations and user fee funding for the Food and Drug Administration
Filing targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to appropriations and user fee funding for the Food and Drug Administration H.R. 1362, the Medical Innovation Never Stops Act, and issues related to FDA operations during a lapse in appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE